Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Binding studies of a monoclonal antibody specific for 3-deoxy-D-manno-octulosonic acid with a panel of Klebsiella pneumoniae lipopolysaccharides representing all of the O serotypes.

van der Meer NM, Appelmelk BJ, Verweij-van Vught AM, Nimmich W, Kosma P, Thijs LG, de Graaff J, MacLaren DM.

Infect Immun. 1994 Mar;62(3):1052-7.

2.

Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins.

Appelmelk BJ, Maaskant JJ, Verweij-van Vught AM, van der Meer NM, Thijs BG, MacLaren DM.

J Gen Microbiol. 1993 Nov;139(11):2641-7.

PMID:
7506295
3.

Polymyxin B-horseradish peroxidase conjugates as tools in endotoxin research.

Appelmelk BJ, Su D, Verweij-van Vught AM, Thijs BG, MacLaren DM.

Anal Biochem. 1992 Dec;207(2):311-6.

PMID:
1481986
4.

Blood substitutes and infection.

Otto BR, Verweij-van Vught AM, MacLaren DM.

Nature. 1992 Jul 2;358(6381):23-4. No abstract available.

PMID:
1614525
5.

Murine ascitic fluids contain varying amounts of an inhibitor that interferes with complement-mediated effector functions of monoclonal antibodies.

Appelmelk BJ, Verweij-Van Vught AM, Maaskant JJ, Thijs LG, MacLaren DM.

Immunol Lett. 1992 Jul;33(2):135-8.

PMID:
1280247
6.

Transferrins and heme-compounds as iron sources for pathogenic bacteria.

Otto BR, Verweij-van Vught AM, MacLaren DM.

Crit Rev Microbiol. 1992;18(3):217-33. Review.

PMID:
1532495
7.

Human immune response to an iron-repressible outer membrane protein of Bacteroides fragilis.

Otto BR, Verweij WR, Sparrius M, Verweij-van Vught AM, Nord CE, MacLaren DM.

Infect Immun. 1991 Sep;59(9):2999-3003.

8.

Iron-regulated outer membrane protein of Bacteroides fragilis involved in heme uptake.

Otto BR, Sparrius M, Verweij-van Vught AM, MacLaren DM.

Infect Immun. 1990 Dec;58(12):3954-8.

9.

Preservatives in insulin preparations impair leukocyte function. In vitro study.

van Faassen I, Verweij-van Vught AM, Lomecky-Janousek MZ, Razenberg PP, van der Veen EA.

Diabetes Care. 1990 Jan;13(1):71-4.

PMID:
2404718
10.

Purification and partial characterization of an iron regulated outer membrane protein of B. fragilis under non-denaturing conditions.

Otto BR, Verweij-Van Vught AM, Maclaren DM.

FEMS Microbiol Lett. 1990 Jan 1;54(1-3):285-90.

PMID:
2323541
11.

Further characterization of monoclonal antibodies to lipopolysaccharide of Salmonella Minnesota strain R595.

Appelmelk BJ, Cohen J, Silva A, Verweij-van Vught AM, Brade H, Maaskant JJ, Schouten WF, Mol O, Honing A, Thijs LG, et al.

Adv Exp Med Biol. 1990;256:319-30.

PMID:
2109505
12.

Epidemiology of the Bacteroides fragilis group in the colonic flora in 10 patients with colonic cancer.

Namavar F, Theunissen EB, Verweij-Van Vught AM, Peerbooms PG, Bal M, Hoitsma HF, MacLaren DM.

J Med Microbiol. 1989 Jul;29(3):171-6.

PMID:
2746627
13.

Comparison of monoclonal antibodies to the deeper core region of gram-negative lipopolysaccharide by means of polymyxin B inhibition studies.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):297-301.

PMID:
2853278
14.

Prevention of lethal endotoxemia in actinomycin D-sensitized mice by incubation of Salmonella minnesota R595 lipopolysaccharide with monoclonal antibodies to R595.

Appelmelk BJ, Verweij-van Vught AM, Brade H, Maaskant JJ, Schouten WF, Thijs LG, MacLaren DM.

Microb Pathog. 1988 Oct;5(4):251-7.

PMID:
2467166
15.

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Schouten WF, De Jonge AJ, Thijs LG, Maclaren DM.

J Med Microbiol. 1988 Jun;26(2):107-14.

PMID:
2455054
16.

Outer membrane proteins of Bacteroides fragilis and Bacteroides vulgatus in relation to iron uptake and virulence.

Otto BR, Verweij-van Vught AM, van Doorn J, Maclaren DM.

Microb Pathog. 1988 Apr;4(4):279-87.

PMID:
3200164
17.
18.

Influence of rosmarinic acid on opsonization and intracellular killing of Escherichia coli and Staphylococcus aureus by porcine and human polymorphonuclear leucocytes.

Verweij-van Vught AM, Appelmelk BJ, Groeneveld AB, Sparrius M, Thijs LG, MacLaren DM.

Agents Actions. 1987 Dec;22(3-4):288-94.

PMID:
3328496
19.

Effect of Bacteroides fragilis cellular components on chemotactic activity of polymorphonuclear leukocytes towards Escherichia coli.

Namavar F, Verweij-Van Vught AM, Bal M, MacLaren DM.

J Med Microbiol. 1987 Sep;24(2):119-24.

PMID:
3309320
20.

Characterization of fimbriae from Bacteroides fragilis.

van Doorn J, Mooi FR, Verweij-van Vught AM, MacLaren DM.

Microb Pathog. 1987 Aug;3(2):87-95.

PMID:
2904638
21.

Heterogeneity of Escherichia coli J5 vaccines.

Appelmelk BJ, Rapson NT, Verweij-van Vught AM, Maaskant JJ, Hekker TA, Peerbooms PG, MacLaren DM, Thijs LG.

Lancet. 1986 Nov 29;2(8518):1273-4. No abstract available.

PMID:
2878147
22.

Cross-reactivity of antibodies to lipopolysaccharides from Escherichia coli J5.

Appelmelk BJ, Verweij-van Vught AM, Maaskant JJ, Thijs LG, MacLaren DM.

J Infect Dis. 1986 Sep;154(3):538-9. No abstract available.

PMID:
3525700
23.

Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

Namavar F, Kaan JA, Verweij-van Vught AM, Vel WA, Bal M, Kester AD, MacLaren DM.

Eur J Clin Microbiol. 1986 Jun;5(3):324-9.

PMID:
3527702
24.

Interactions between polymorphonuclear leucocytes, Bacteroides sp, and Escherichia coli: their role in the pathogenesis of mixed infection.

Vel WA, Namavar F, Verweij-van Vught AM, Pubben AN, MacLaren DM.

J Clin Pathol. 1986 Apr;39(4):376-82.

25.

The role of K antigens as virulence factors in Klebsiella.

Simoons-Smit AM, Verweij-van Vught AM, MacLaren DM.

J Med Microbiol. 1986 Mar;21(2):133-7.

PMID:
3512838
26.

Pathogenic synergy between Escherichia coli and Bacteroides fragilis or B. vulgatus in experimental infections: a non-specific phenomenon.

Verweij-van Vught AM, Namavar F, Vel WA, Sparrius M, MacLaren DM.

J Med Microbiol. 1986 Feb;21(1):43-7.

PMID:
3512833
27.

An enzyme-linked immunosorbent assay (ELISA) for the measurement of antibodies to different parts of the gram-negative lipopolysaccharide core region.

Appelmelk BJ, Verweij-Van Vught AM, MacLaren DM, Thijs LG.

J Immunol Methods. 1985 Oct 10;82(2):199-207.

PMID:
2413127
28.

Biochemical and serological investigations on clinical isolates of klebsiella.

Simoons-Smit AM, Verweij-Van Vught AM, Kanis IY, MacLaren DM.

J Hyg (Lond). 1985 Oct;95(2):265-76.

29.

Chemiluminescence of human leukocytes stimulated by clinical isolates of Klebsiella.

Simoons-Smit AM, Verweij-van Vught AM, Kanis IY, MacLaren DM.

J Med Microbiol. 1985 Jun;19(3):333-8.

PMID:
4009688
30.

Pathogenic synergy between Escherichia coli and Bacteroides fragilis: studies in an experimental mouse model.

Verweij-van Vught AM, Namavar F, Sparrius M, Vel WA, MacLaren DM.

J Med Microbiol. 1985 Jun;19(3):325-31.

PMID:
3892009
31.

Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.

Vel WA, Namavar F, Verweij-van Vught AM, Pubben AN, MacLaren DM.

J Clin Pathol. 1985 Jan;38(1):86-91.

32.

Polymorphonuclear leukocyte chemotaxis by mixed anaerobic and aerobic bacteria.

Namavar F, Verweij-Van Vught AM, Vel WA, Bal M, MacLaren DM.

J Med Microbiol. 1984 Oct;18(2):167-72.

PMID:
6387126
33.

The role of different K antigens of Escherichia coli in phagocytosis by polymorphonuclear leukocytes.

Verweij-Van Vught AM, Namavar F, Peerbooms PG, Sparrius M, Maclaren DM.

J Med Microbiol. 1984 Apr;17(2):141-50.

PMID:
6142958
34.

Pathogenic synergy: mixed intra-abdominal infections.

MacLaren DM, Namavar F, Verweij-Van Vught AM, Vel WA, Kaan JA.

Antonie Van Leeuwenhoek. 1984;50(5-6):775-87. Review.

PMID:
6397140
35.

Comparison of different methods for bacteriocin typing of Klebsiella strains.

Simoons-Smit AM, Verweij-van Vught AM, Kanis IY, Maclaren DM.

J Hyg (Lond). 1983 Jun;90(3):461-73.

36.

K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model.

Verweij-van Vught AM, van den Bosch JF, Namavar F, Sparrius M, MacLaren DM.

J Med Microbiol. 1983 May;16(2):147-55.

PMID:
6341596
37.

Virulence of mecillinam-resistant spherical mutants of Klebsiella pneumoniae and Escherichia coli.

Verweij-van Vught AM, Namavar F, Smit AM, Sparrius M, MacLaren DM.

J Antimicrob Chemother. 1982 May;9(5):379-85. No abstract available.

PMID:
6284694

Supplemental Content

Loading ...
Support Center